Global Liver Institute has consistently advocated for a more muscular and proactive set of solutions for transplant recipients, cancer patients, and individuals with compromised immune systems...
(Washington, D.C., Monday, July 26, 2021)—Global Liver Institute (GLI) today urged the U.S. Food and Drug Administration to expedite the review of growing safety and effectiveness data and approve...
(Washington, D.C., Thursday, July 15, 2021)—Global Liver Institute (GLI) is urging the U.S. Office of Management and Budget (OMB) to implement fixes to the organ transplantation system rife with...
(Washington, D.C., Wednesday, July 7, 2021)—Global Liver Institute (GLI) today announced the hiring of Robert Mitchell-Thain, a prominent international patient advocate, to the newly created...
POLICY PERSPECTIVE As a patient advocacy organization committed to improving the lives of all transplant recipients, Global Liver Institute (GLI) appreciates the continued leadership of medical...
(Washington. D.C., Thursday, June 10, 2021)—Global Liver Institute (GLI), the worldwide leader in liver health advocacy, is pleased to announce a partnership with NutriStyle Inc. to...
WASHINGTON, D.C.—Global Liver Institute (GLI) is convening the fourth International NASH Day on June 10, 2021, at 2 a.m. Eastern, United States. Eight virtual panels of international experts will...
(Washington, D.C., Thursday, May 27, 2021)—Global Liver Institute (GLI) today formally announced its Liver Action Network, a national U.S. initiative to connect liver patients, caregivers, and...
WASHINGTON, D.C.—Global Liver Institute (GLI) will convene the fourth International NASH Day on June 10, 2021. Eight virtual panels of international experts will shed light on nonalcoholic...
As COVID-19 vaccines roll out, more and more schools and workplaces are inching toward fully reopening for in-person work or instruction. While the mental health challenges of being disconnected...
Recent News
GLI Celebrates FDA Approval of Livdelzi®, an Option in Personalizing PBC Treatment (Washington, D.C. August 14, 2024) – Global Liver Institute (GLI) celebrates the expansion of treatment options for patients with primary biliary cholangitis (PBC) after the U.S. Food...
Congress is entering the August recess period. Nevertheless, patients are increasingly signaling to policymakers their frustration related to coverage challenges and over-zealous utilization management practices such as non-medical switching and other barriers...
NASH Affects Millions, But the Future for Treatment Remains Brighter Than Ever Managing NASH/MASH is becoming more promising with new advancements. The recent FDA approval of resmetirom, which offers hope for those with moderate-to-advanced liver scarring, marks...
Thank you for reading Liver Cancer News! Liver cancer is associated with low five-year survival rates, often due to late-stage diagnosis of the disease. In many cases, symptoms are minimal or absent until the cancer has progressed significantly, at which point...
New App Helps Predict Pediatric Transplant Need Amplify your voice with the new Wilson’s disease advocacy toolkit Following the Policy brief on Wilson’s disease in 2023, the Health Partnership has officially published their Wilson’s disease advocacy...
